Revealed: This Pot Stock Could Soon Pay a Dividend

Aphria’s (TSX:APHA)(NYSE:APHA) CFO just confirmed it. The company could be the first pot producer to pay a regular dividend.

Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

One of the biggest stories in Canadian business over the latter half of 2019 was the massive implosion of Canada’s marijuana sector. Leading pot stocks fell as much as 50-75%.

A number of factors contributed to the fall, but mostly it came down to sentiment. Investors went from being incredibly bullish on the future of legal marijuana in Canada to realizing there was way too much supply in the system, all within the span of a few months. We’re now in a period of reckoning, which will undoubtedly end with some of the weaker producers going bankrupt.

Amid all this carnage could be an interesting buying opportunity. The legal pot market should continue to grow, as more kinks get ironed out of the system and as marijuana edibles become more popular. Many smokers still have their dealer on speed dial — something that should begin to change as more stores open with more consistent supply. And some of the top marijuana producers are finally starting to get serious about profitability, which is always a good thing for investors.

One pot stock is even considering a pretty major step — something that will immediately make it leap onto certain investors’ radars.

Dividend-paying marijuana?

Aphria (TSX:APHA)(NYSE:APHA) recently released its quarterly numbers, and the stock sold off some 8% on the news.

Investors were disappointed in top-line results. Revenue was expected to be $130 million, but actual numbers came up short, with the company only posting $121 million in sales. The company also cut its full-year revenue forecast, slashing sales estimates from $650 to $700 million to a range of $575 to $625 million.

It wasn’t all bad news, however. The company reported a tiny $1.9 million adjusted EBITDA profit in its most recent quarter and projected the adjusted EBITDA would be between $35 and $42 million for the year. In a world filled with marijuana companies that will still struggle for any sort of profitability in 2020, Aphria stands as a rare beacon of strength.

Aphria also has a strong balance sheet with nearly $400 million in cash. It’s well positioned to gobble up any prime assets from any struggling marijuana producers. And with serious profitability just around the corner, the company is even looking at sending money back to shareholders.

During the conference call discussing this quarter’s earnings with analysts, Aphria’s CFO told investors the company was strongly considering paying the sector’s first consistent dividend.

As part of his remarks, CFO Carl Merton told investors the company looks forward to “in the future being in the position to provide an annual return to our shareholders through dividends.”

Merton and the rest of Aphria’s management team didn’t mention a specific date, but I think the company could institute a regular dividend by the end of 2020, depending on whether it can deliver on its profitability goals.

Paying a regular dividend could give Aphria one major advantage over its peers. There are hundreds of Canadian mutual funds and exchange-traded funds that insist on only investing in stocks that pay a dividend. These funds are likely to have big interest in adding a fast-growing marijuana producer to their portfolios. They’re just waiting for such a company to become profitable enough a regular dividend is a possibility.

The bottom line

Although Aphria shares are reeling after cutting guidance, this dividend chatter is good news. It shows management is confident in the future and that the company is serious about profitability. The best returns going forward will come from pot producers who can show they can make consistent profits. Aphria isn’t quite there yet, but I like the direction it’s heading.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Nelson Smith has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »